Ectopic pregnancy: recognition, management, and what comes next

What ectopic pregnancy means

Ectopic pregnancy occurs when a fertilised egg implants somewhere other than the lining of the uterus. Around 98% of ectopic pregnancies are tubal — most commonly in the ampulla of the fallopian tube, though the isthmus, fimbriae, and interstitial (cornual) segments can also be affected. The remaining 2% implant on the ovary, cervix, or caesarean-section scar. Scar ectopics are increasing as caesarean rates rise, and represent a distinct clinical challenge.

In Australia, ectopic pregnancy affects approximately 1.5–2% of all pregnancies (RANZCOG C-Gyn 38, 2024) and remains the leading cause of maternal death in the first trimester. The AIHW maternal deaths report estimates that ectopic pregnancy has historically accounted for around 10% of pregnancy-related maternal deaths in Australia — not because it is common, but because haemorrhage from a ruptured tube can be fatal within hours.

The classical triad — unilateral abdominal pain, vaginal bleeding, and amenorrhoea — occurs in fewer than half of presentations. Many patients have only mild, non-specific symptoms. This is the diagnostic challenge: the patient who is quietly deteriorating before tubal rupture can present with nothing more alarming than some spotting and a vague ache. General practice is often where the diagnosis is first considered, and the GP’s role is to suspect, test, and escalate without delay.

---

A. Core clinical — the AU general-practice framework

Who is at risk

Risk factors for ectopic pregnancy reflect any condition that damages the fallopian tube or impairs its function:

• Prior ectopic pregnancy — 10–15% recurrence risk; the single strongest predictor
• Pelvic inflammatory disease or chlamydia — tubal inflammation raises ectopic risk 3–4-fold; subclinical infection is common and often unrecognised
• Tubal surgery — sterilisation (clip, ring, cautery), reversal procedures, or prior salpingostomy
• Assisted reproductive technology (IVF or ICSI) — ectopic risk is approximately 1.5–4 times background rate; heterotopic pregnancy (simultaneous intrauterine and ectopic) occurs in roughly 1% of IVF pregnancies
• IUD in situ at conception — IUDs reduce conception overall, but if conception occurs, the proportion that are ectopic is higher
• Age over 35, smoking, and endometriosis are additional independent risk factors

Importantly, roughly 50% of ectopic pregnancies occur without any identifiable risk factor. Any person of reproductive age with abdominal pain or vaginal bleeding needs a urine pregnancy test — risk stratification alone cannot safely exclude the diagnosis.

History and presenting symptoms

Any woman of reproductive age with abdominal pain, vaginal bleeding, or a missed period should have a urine βhCG performed at that visit. Do not defer to await a “more obvious” clinical picture.

Key symptoms to ask about:

• Lower abdominal pain — present in 60–90%; characteristically unilateral; can be mild cramping initially, becoming severe with rupture
• Vaginal bleeding — present in 50–80%; typically lighter than a period and often dark (“prune juice” spotting)
• Missed or late period — present in ~75%, though some patients may not recognise the amenorrhoea if spotting has been interpreted as a light period
• Shoulder-tip pain — referred from haemoperitoneum tracking under the diaphragm; a late and serious sign
• Dizziness, fainting, or near-syncope — haemoperitoneum
• Urge to defecate with significant pain — blood pooling in the pouch of Douglas

Also ask about: last menstrual period, contraception history, all prior pregnancies (including terminations), any IVF cycles, history of pelvic infection or STIs, prior pelvic or abdominal surgery.

Examination

Vital signs come first. Tachycardia (heart rate above 100 bpm) in a young person is not normal. If a woman has lower abdominal pain, a positive pregnancy test, and tachycardia — treat as haemodynamic instability until proved otherwise.

Abdominal examination: assess for unilateral or bilateral tenderness; guarding or rebound indicates peritonism (rupture); shoulder-tip tenderness on deep inspiration indicates diaphragmatic irritation from free intraperitoneal blood.

Do not perform vigorous bimanual palpation in suspected ectopic pregnancy — there is a real risk of precipitating haemorrhage. Gentle speculum inspection to confirm the source of bleeding is reasonable if clinically indicated.

Investigations in general practice

1. Urine βhCG — the first investigation; sensitive to approximately 25 IU/L, positive 10–14 days post-conception
2. Serum βhCG — quantitative; baseline plus repeat at 48 hours. In a normal intrauterine pregnancy, βhCG rises by more than 53–66% over 48 hours (Barnhart et al., Obstet Gynecol 2004). A suboptimal rise, plateau, or decline indicates an abnormal pregnancy — ectopic or miscarrying — but cannot distinguish the two without imaging
3. Blood group and antibody screen — essential; Rh-negative patients need anti-D immunoglobulin
4. FBC — baseline haemoglobin; assess degree of blood loss
5. Transvaginal ultrasound (TVUS) — arranged urgently via the early pregnancy assessment service (EPAS) or hospital imaging; the diagnostic gold standard (RANZCOG C-Gyn 38)

Immediate triage

• Haemodynamic instability (heart rate above 100, blood pressure below 100/60, pallor, diaphoresis, syncope, peritonism, severe pain) → call 000, commence resuscitation (IV access, oxygen, fluid), notify the receiving hospital and O&G team. This is a ruptured ectopic until proven otherwise.
• Clinically stable with positive pregnancy test and symptoms → same-day referral to EPAS or O&G. Phone ahead rather than sending a referral letter.
• Positive pregnancy test with prior failed intrauterine confirmation → urgent EPAS review.

---

B. The investigation pathway — βhCG dynamics and pregnancy of unknown location

What serial βhCG tells us

When TVUS does not show either an intrauterine pregnancy or a visible ectopic mass, the situation is described as a pregnancy of unknown location (PUL). This occurs in roughly 10% of positive pregnancy tests presenting to early pregnancy services, and around 8–14% of PULs will ultimately prove to be ectopic.

Management of PUL depends on 48-hourly βhCG measurement:

• ≥66% rise → likely viable intrauterine pregnancy; repeat TVUS in 1–2 weeks
• ≥50% fall → likely resolved (failing intrauterine pregnancy or spontaneously resolving PUL); confirm with weekly βhCG to undetectable level
• Intermediate result (slow rise, plateau, or slow decline) → continued ectopic risk; repeat TVUS, low threshold for diagnostic laparoscopy if symptomatic or βhCG stalls

The βhCG discriminatory zone — approximately 1500 IU/L (NICE) to 2400 IU/L (RCOG) — is the threshold above which a viable intrauterine pregnancy should be visible on a good-quality TVUS. An empty uterus above the discriminatory zone is ectopic until proved otherwise. Different centres use slightly different thresholds depending on their TVUS resolution and local protocols.

The GP’s role with a confirmed or suspected PUL is to organise the first βhCG pair, ensure handover to EPAS, and communicate a clear safety-netting message about what symptoms should prompt immediate return or emergency attendance.

The IVF exception: heterotopic pregnancy

A heterotopic pregnancy — simultaneous intrauterine and ectopic pregnancy — occurs in approximately 1% of IVF pregnancies. Finding an intrauterine gestational sac on TVUS does not exclude a co-existing ectopic in a patient who has used assisted reproduction. Any IVF patient who continues to have symptoms after an intrauterine pregnancy has been identified on scan must be assessed for heterotopic pregnancy. Methotrexate cannot be used in this situation (it would be teratogenic to the intrauterine pregnancy); surgical removal of the ectopic with preservation of the intrauterine pregnancy is the approach.

---

C. Treatment options — expectant, medical, and surgical

Definitive management decisions belong with the EPAS or O&G team. What follows summarises the framework patients will encounter, drawn from RANZCOG C-Gyn 38 and eTG.

Expectant management

Selected stable patients with βhCG below 1500 IU/L that is already declining spontaneously, no fetal heartbeat on TVUS, and a small adnexal mass may be candidates for expectant management — close observation without active intervention. Success rates are approximately 70%. Twice-weekly βhCG until undetectable is required, and the patient must have a clear plan for immediate return if symptoms worsen.

Medical management — methotrexate

Methotrexate (AMH) given as an intramuscular injection stops the ectopic pregnancy from growing. The success rate is approximately 85% in carefully selected patients.

Eligibility criteria (per RANZCOG C-Gyn 38):

• Haemodynamic stability
• βhCG below 5000 IU/L
• No fetal cardiac activity on TVUS
• Adnexal mass below 35 mm
• No significant haemoperitoneum
• No contraindications: renal, hepatic, or pulmonary disease; active peptic ulcer; thrombocytopenia or neutropenia; alcohol use disorder; breastfeeding; immunodeficiency

Follow-up: βhCG on day 4 and day 7 after the injection. A fall of ≥15% between day 4 and day 7 confirms response. Weekly βhCG then continues to an undetectable level — this typically takes 4–6 weeks.

Post-methotrexate instructions — critically important for general-practice follow-up: avoid folic acid supplements (interfere with drug action and must only be restarted once methotrexate is fully cleared); avoid NSAIDs (renal interaction), alcohol, and sun exposure; avoid conception for at least three months due to teratogenicity risk.

Surgical management

Laparoscopy is the definitive surgical approach. Salpingectomy (removal of the affected tube) is preferred over salpingostomy (tube-preserving incision) when the contralateral tube is healthy — the ESEP randomised trial (Lancet 2014) showed equivalent subsequent live-birth rates and a lower risk of persistent trophoblastic tissue (requiring further treatment) with salpingectomy. Salpingostomy is considered when the contralateral tube is damaged or absent.

Open laparotomy is reserved for haemodynamically unstable patients or where laparoscopic access is not feasible.

---

D. Australian operations

Early pregnancy assessment services

Every major Australian hospital operates an EPAS or equivalent early pregnancy unit. GPs should phone ahead rather than writing a referral letter — a same-day assessment is the standard for suspected ectopic pregnancy. In rural or remote areas, arrange direct emergency department referral and coordinate a telephone consultation with the nearest O&G service.

MBS items

Standard time-tiered GP consultations (MBS items 23, 36, 44) cover the initial assessment. Serum βhCG and FBC are Medicare-rebatable pathology items. Transvaginal ultrasound for early pregnancy assessment is billed under MBS items 55700/55701. The 75+ Health Assessment (item 703) is not applicable here, but for the 6-week follow-up visit, a standard long consultation (item 36 or 44) is appropriate. Mental Health Care Plans (items 2715/2717) can be initiated for grief following pregnancy loss, providing up to 10 subsidised psychology sessions per year via the Better Access initiative. Telehealth equivalents apply for follow-up where the 12-month existing-relationship rule is met; initial assessment requires face-to-face attendance.

Anti-D immunoglobulin

All Rh-negative patients must receive anti-D immunoglobulin within 72 hours of any bleeding, intervention, or confirmed diagnosis — 250 IU IM before 12 weeks gestation; 625 IU IM at or after 12 weeks (Australian Red Cross Lifeblood). This is managed through the EPAS or hospital setting. At the 6-week GP review, confirm anti-D was administered and document in the patient’s record.

Psychological support and follow-up

Ectopic pregnancy is a pregnancy loss and is experienced as grief — this is not a minor procedural event. At the 6-week follow-up:

• Screen for depression (PHQ-9) and perinatal anxiety/depression (EPDS)
• Discuss future fertility and contraception
• Confirm immunisation status (rubella, varicella)
• Initiate a Mental Health Care Plan if indicated

Peer support resources: SANDS Australia, Pink Elephants Support Network (early pregnancy loss peer support), PANDA helpline 1300 726 306.

---

E. Special populations

Aboriginal and Torres Strait Islander patients

Higher background rates of pelvic inflammatory disease and chlamydia, and lower rates of early engagement with antenatal care, mean that ectopic risk is elevated and diagnosis may come later. A culturally safe approach is essential: involve an Aboriginal Health Worker or Aboriginal and Torres Strait Islander liaison officer where available, use MBS item 715 (Aboriginal and Torres Strait Islander Health Assessment) when appropriate, and connect with the local Aboriginal Community Controlled Health Organisation. Closing the Gap PBS co-payment applies to relevant post-discharge prescriptions. The GP must proactively recall this patient group.

Patients who have used assisted reproductive technology

As noted in section B, heterotopic pregnancy risk is approximately 1 in 100 IVF pregnancies. Patients who have had embryo transfer should understand that a confirmed intrauterine pregnancy on TVUS does not exclude a simultaneous ectopic if symptoms persist. TVUS is routinely performed at 6–7 weeks post-transfer and will detect most heterotopic pregnancies.

Rh-negative patients

Rh status must be confirmed at presentation. Anti-D immunoglobulin must be arranged without delay through the managing service. Document at the 6-week review that it was administered.

Patients with a history of prior salpingectomy

Removal of one tube does not eliminate ectopic risk — ovarian, cervical, caesarean-scar, and contralateral-tube ectopics remain possible. Maintain vigilance in any subsequent pregnancy in this group.

---

When to escalate

Call 000 or arrange immediate emergency transfer for:

• Heart rate above 100 bpm with a positive pregnancy test
• Systolic blood pressure below 100 mmHg
• Pallor, diaphoresis, syncope, or near-syncope
• Peritonism: guarding, rebound tenderness, rigid abdomen
• Shoulder-tip pain with abdominal tenderness
• Any rapid deterioration

Refer same-day to EPAS or O&G for:

• Positive pregnancy test with any lower abdominal pain or vaginal bleeding
• Serum βhCG not rising as expected on serial measurement
• TVUS showing adnexal mass with empty uterus
• Pregnancy of unknown location with plateauing or rising βhCG
• Prior ectopic pregnancy with new symptoms

---

What this article is and is not

This is general health information based on current Australian guidelines — RANZCOG C-Gyn 38, eTG, and the AMH — and peer-reviewed evidence. It is not personal medical advice and does not create a doctor–patient relationship. Individual clinical decisions — including investigation sequencing, treatment selection, and follow-up — are made with the treating clinicians involved in a specific patient’s care.

For consumer-friendly information: HealthDirect — Ectopic pregnancy, The Royal Women’s Hospital patient information.

For pregnancy loss support: SANDS Australia, Pink Elephants Support Network, PANDA 1300 726 306.

For acute mental health crisis: Lifeline 13 11 14 · Beyond Blue 1300 22 4636.

---

Sources cited

1. RANZCOG — C-Gyn 38: Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (2024)
2. RCOG Green-top Guideline 21 — Diagnosis and Management of Ectopic Pregnancy (2016)
3. NICE NG126 — Ectopic pregnancy and miscarriage (2019)
4. Therapeutic Guidelines (eTG) — Ectopic pregnancy
5. Australian Medicines Handbook — Methotrexate
6. Australian Red Cross Lifeblood — Anti-D immunoglobulin
7. AIHW — Maternal deaths in Australia
8. Barnhart KT et al. — Serial βhCG in early pregnancy. Obstet Gynecol 2004
9. ESEP trial — salpingectomy vs salpingostomy. Lancet 2014
10. HealthDirect — Ectopic pregnancy
11. The Royal Women’s Hospital — Ectopic pregnancy
12. SANDS Australia
13. Pink Elephants Support Network
14. PANDA — perinatal anxiety and depression
15. Better Access initiative